About me

Data Scientist with over 7 years of proficiency in machine learning, data science, and statistical analysis. Extensive experience in collaborating and communicating with experts from interdisciplinary fields. Passionate about crafting innovative AI and ML solutions, staying up-to-date with technology advancements such as generative AI, and emphasizing model interpretability for explainable results.

Publications

You can also find a list of my published work on Google Scholar.

1. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery.
   R. T. Chou, A. Ouattara, M. Adams, A. A. Berry, S. Takala-Harrison, M. P. Cummings
   npj Systems Biology and Applications (2024). [PDF] [BibTeX] [PubMed] [Source Code]

2. Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats.
   H. T. Hsueh^$*$, R. T. Chou^$*$ (co-first author), U. Rai, P. Kolodziejski, W. Liyanage, J. Pejavar, A. Mozzer, C. Davison, M. B. Appell, Y. C. Kim, K. T. Leo, H. Kwon, M. Sista, N. M. Anders, A. Hemingway, S. V. K. Rompicharla, I. Pitha, D. J. Zack, J. Hanes, M. P. Cummings, L. M. Ensign
   Journal of Controlled Release (2023). [PDF] [BibTeX] [PubMed] [Source Code]

3. Using machine learning to understand the relationships between audiometric data, speech perception, temporal processing, and cognition.
   R. M. Khalil, A. Papanicolaou, R. T. Chou, B. E. Gibbs, S. Anderson, S. Gordon-Salant, M. P. Cummings, M. J. Goupell
   2023 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP) (2023). [PDF] [BibTeX]

4. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery.
   H. T. Hsueh^$*$, R. T. Chou^$*$ (co-first author), U. Rai, W. Liyanage, Y. C. Kim, M. B. Appell, J. Pejavar, K. T. Leo, C. Davison, P. Kolodziejski, A. Mozzer, H. Kwon, M. Sista, N. M. Anders, A. Hemingway, S. V. K. Rompicharla, M. Edwards, I. Pitha, J. Hanes, M. P. Cummings, L. M. Ensign
   Nature Communications (2023). [PDF] [BibTeX] [PubMed] [Source Code] [UMIACS News] [Hopkins Medicine News]

5. A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.
   Y. C. Kim, H. T. Hsueh, M. D. Shin, C. A. Berlinicke, H. Han, N. M. Anders, A. Hemingway, K. T. Leo, R. T. Chou, H. Kwon, M. B. Appell, U. Rai, P. Kolodziejski, C. Eberhart, I. Pitha, D. J. Zack, J. Hanes, L. M. Ensign
   Drug Delivery and Translational Research (2022). [PDF] [BibTeX] [PubMed]

6. Ion-complex microcrystal formulation provides sustained delivery of a multimodal kinase inhibitor from the subconjunctival space for protection of retinal ganglion cells.
   H. T. Hsueh, Y.-C. Kim, I. Pitha, M. D. Shin, C. A. Berlinicke, R. T. Chou, E. Kimball, J. Schaub, S. Quillen, K. T. Leo, H. Han, A. Xiao, Y. Kim, M. Appell, U. Rai, H. Kwon, P. Kolodziejski, L. Ogunnaike, N. M. Anders, A. Hemingway, J. L. Jefferys, A. A. Date, C. Eberhart, T. V. Johnson, H. A. Quigley, D. J. Zack, J. Hanes, L. M. Ensign
   Pharmaceutics (2021). [PDF] [BibTeX] [PubMed]

Fun facts